Additional Proxy Soliciting Materials (definitive) (defa14a)
March 28 2016 - 5:21PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the
Registrant
x
Filed by
a party other than the Registrant
¨
Check the appropriate box:
|
|
|
¨
|
|
Preliminary Proxy Statement
|
|
|
¨
|
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
|
¨
|
|
Definitive Proxy Statement
|
|
|
x
|
|
Definitive Additional Materials
|
|
|
¨
|
|
Soliciting Material Pursuant to §240.14a-12
|
Affymetrix, Inc.
(Name
of Registrant as Specified In Its Charter)
(Name of Person(s)
Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
|
|
|
|
|
|
|
x
|
|
No fee required.
|
|
|
¨
|
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
|
|
|
|
(1)
|
|
Title of each class of securities to which transaction applies:
|
|
|
(2)
|
|
Aggregate number of securities to which transaction applies:
|
|
|
(3)
|
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing
fee is calculated and state how it was determined):
|
|
|
(4)
|
|
Proposed maximum aggregate value of transaction:
|
|
|
(5)
|
|
Total fee paid:
|
|
|
¨
|
|
Fee paid previously with preliminary materials.
|
|
|
¨
|
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing.
|
|
|
|
|
|
(1)
|
|
Amount previously paid:
|
|
|
(2)
|
|
Form, Schedule or Registration Statement No.:
|
|
|
(3)
|
|
Filing party:
|
|
|
(4)
|
|
Date Filed:
|
Memorandum
|
|
|
|
|
DATE:
|
|
March 28, 2016
|
|
Affymetrix, Inc.
3420 Central Expressway
Santa Clara, CA 95051
www.affymetrix.com
|
TO:
|
|
All Affymetrix Employees
|
|
FROM:
|
|
Frank Witney
|
|
SUBJECT:
|
|
Acquisition Update
|
|
Dear Global Affymetrix team,
You may have seen our press release this morning stating that the Affymetrix board reaffirmed its support of our merger with Thermo Fisher and recommended
against the Origin Technologies proposal. This conclusion was reached after an extensive investment of time and resources by Affymetrix management and its legal and financial advisors engaging with Origin. The Board carefully considered many
factors, as outlined in the press release, and concluded that the merger with Thermo Fisher constituted the highest value proposition reasonably available to Affymetrix stockholders. As a result, we will proceed to a shareholder vote at
the Special Stockholder Meeting that is scheduled to reconvene this Thursday March 31
st
.
The Senior
Leadership Team very much appreciates your continued focus on the task at hand as we come down the home stretch in Q1, as well as your attention, in some cases, to integration planning activities with Thermo Fisher.
Sincerely,
Frank Witney
President &
Chief Executive Officer
Important Information for Affymetrix Stockholders
In connection with the proposed merger, Affymetrix has filed a proxy statement with the Securities and Exchange Commission (the SEC).
STOCKHOLDERS ARE ADVISED TO READ THE PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) FILED WITH THE SEC ON FEBRUARY 24, 2016 BECAUSE IT CONTAINS IMPORTANT INFORMATION. Stockholders may obtain a free copy of the proxy statement
and any other relevant documents filed with the SEC from the SECs website at
http://www.sec.gov
. In addition, stockholders will be able to obtain, without charge, a copy of the proxy statement and other relevant documents at
Affymetrix website at investor.Affymetrix.com or by contacting Affymetrix investor relations department via e-mail at
investor@affymetrix.com
.
Affymetrix and its directors, executive officers and other members of its management and employees as well as Thermo Fisher and its directors and
executive officers may be deemed to be participants in the solicitation of proxies from Affymetrix stockholders with respect to the merger. Information about Affymetrix directors and executive officers and their ownership of
Affymetrix common stock is set forth in the proxy statement for Affymetrix 2016 Special Meeting of Stockholders, Affymetrix Annual Report on
Form 10-K
for the fiscal year ended
December 31, 2015 and proxy statement for Affymetrix 2015 Annual Meeting of Stockholders. Information about Thermo Fishers directors and executive officers is set forth in the proxy statement for Thermo Fishers 2015 Annual
Meeting of Stockholders. Stockholders may obtain additional information regarding the direct and indirect interests of the participants in the solicitation of proxies in connection with the merger, including the interests of Affymetrix
directors and executive officers in the merger, which may be different than those of Affymetrix stockholders generally, by reading the proxy statement and other relevant documents regarding the merger, which have been filed with the SEC.
Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Jul 2023 to Jul 2024